Clinical Trials
6 trialsNCT05498792 2026-05-22
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
Fox Chase Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT05704933 2026-04-06
Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Completed
NCT05358938 2026-02-06
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Active not recruiting
NCT03526185 2022-07-25
A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes
Yale University
Phase EARLY_PHASE1 Terminated
NCT00972933 2017-12-07
Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT01730157 2016-03-10
Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated